AllianceBernstein Holding L.P. (AB)
Track the next or latest earnings date for AllianceBernstein Holding L.P., review consensus estimates, and see cached AI analysis for recent quarterly results.
Recent earnings news
finance.yahoo.com · 1 day ago
While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making. Here at Zacks, we prioritize apprais…
Why is SAAB stock surging today? By Investing.cominvesting.com · 12 hours ago
Investing.com -- SAAB AB ser. B stock surged 5.1% today after Morgan Stanley issued a double-upgrade on the Swedish defense group, shifting its rating from Underweight to Overweight and raising its 12-month price target to SEK 700 from SEK 540. The bank’s bullish repositioning reflected a view that …
Investor AB B highlights long-term portfolio role as Swedish investment housead-hoc-news.de · 10 hours ago
The B shares traded on the Stockholm exchange provide a liquid way for market participants to participate in this strategy. The company typically holds large, long-term positions rather than engaging in short-term trading. These holdings span sectors such as industrial manufacturing, financial servi…
ABT Stock | Abbott Laboratories Price, Quote, News & Analysis - TipRanks.comwww.tipranks.com · 2 weeks ago
Abbott Laboratories lowest stock price was $81.97 and its highest was $139.06 in the past 12 months. ... Abbott Laboratories’s market cap is $160.56B. When is Abbott Laboratories’s upcoming earnings report date?
Abbott Laboratories Q2 Earnings Preview: A Contrarian Buy Opportunity Worth Considering | Seeking Alphaseekingalpha.com · 4 days ago
Abbott Laboratories (ABT) is due to announce its Q2 2026 earnings around 16th July - the Life Sciences giant has endured a difficult 6 months, its share price down >20%, and in fact 18% on a · If you are interested in keeping up to date with stocks making moves within the biotech, pharma, ...
Latest earnings date
Time not specified
Fiscal quarter: 2025-12-31
EPS estimate: $0.95
Revenue estimate: N/A
Market cap: $3.29B
Analysis snapshot
No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.
Recent earnings history
Browse the calendar week| Date | Quarter | Report window | EPS est. | Revenue est. |
|---|---|---|---|---|
| Feb 05, 2026 | 2025-12-31 | Time not specified | $0.95 | N/A |